Endothelin-receptor antagonists in the management of pulmonary arterial hypertension: where do we stand?

Endothelin-receptor antagonists in the management of pulmonary arterial hypertension: where do we stand?

Michele Correale,1 Armando Ferraretti,2 Ilenia Monaco,3 Davide Grazioli,1 Matteo Di Biase,4 Natale Daniele Brunetti3 1Department of Cardiology, Ospedali Riuniti University Hospital, Foggia, 2Cardiology Unit, “Caduti in guerra” Hospital, Canosa di Puglia, BT, 3Department of Cardio...

Full description

Bibliographic Details
Main Authors: Correale M, Ferraretti A, Monaco I, Grazioli D, Di Biase M, Brunetti ND
Format: Article
Language:English
Published: Dove Medical Press 2018-10-01
Series:Vascular Health and Risk Management
Subjects:
Endothelin Receptor Antagonists
Pulmonary Arterial Hypertension
Bosentan
Ambrisentan
Sitaxetan
Macitentan.
Online Access:https://www.dovepress.com/endothelin-receptor-antagonists-in-the-management-of-pulmonary-arteria-peer-reviewed-article-VHRM

Internet

https://www.dovepress.com/endothelin-receptor-antagonists-in-the-management-of-pulmonary-arteria-peer-reviewed-article-VHRM

Similar Items